Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-07
DOI
10.1038/s41388-022-02340-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism
- (2021) Jie Li et al. Nature Communications
- Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders
- (2021) Anja Dölle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase separation drives aberrant chromatin looping and cancer development
- (2021) Jeong Hyun Ahn et al. NATURE
- A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
- (2021) Xufen Yu et al. Science Translational Medicine
- Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q
- (2021) Isaac Park et al. Cancers
- Ikaros Proteins in Tumor: Current Perspectives and New Developments
- (2021) Ruolan Xia et al. Frontiers in Molecular Biosciences
- Discovery of WD Repeat-Containing Protein 5 (WDR5)–MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2020) Selena Chacón Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells
- (2020) Annalisa Romanelli et al. ACS Medicinal Chemistry Letters
- Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity
- (2019) Erin R. Aho et al. Cell Reports
- PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation
- (2019) Zhihong Ren et al. BLOOD
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5–MYC Protein–Protein Interaction
- (2019) Jonathan D. Macdonald et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core
- (2019) Jianhua Tian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders
- (2018) Mette Ishoey et al. ACS Chemical Biology
- Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
- (2018) Afua A. Akuffo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Potent 2-Aryl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2018) Feng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of thalidomide enantiomer binding to cereblon
- (2018) Tomoyuki Mori et al. Scientific Reports
- Moonlighting with WDR5: A Cellular Multitasker
- (2018) Alissa Guarnaccia et al. Journal of Clinical Medicine
- ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer
- (2018) Ling Cai et al. MOLECULAR CELL
- Bruton's Tyrosine Kinase degradation as a therapeutic strategy for cancer
- (2018) Dennis Dobrovolsky et al. BLOOD
- Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction
- (2017) Hacer Karatas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase
- (2017) Jian An et al. Nature Communications
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
- (2016) Elizabeth C. Townsend et al. CANCER CELL
- Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development
- (2016) Rui Lu et al. CANCER CELL
- High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity
- (2016) Dong-Dong Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes
- (2016) Nilda L. Alicea-Velázquez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)
- (2016) Matthäus Getlik et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
- (2016) Mary E. Matyskiela et al. NATURE
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- WDR5 high expression and its effect on tumorigenesis in leukemia
- (2016) Zheng Ge et al. Oncotarget
- In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
- (2016) Alessandro Carugo et al. Cell Reports
- MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program
- (2016) Jing Xu et al. Cell Discovery
- An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition
- (2016) Brian Egan et al. PLoS One
- WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
- (2015) Y. Sun et al. CANCER RESEARCH
- Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC
- (2015) Lance R. Thomas et al. MOLECULAR CELL
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
- (2015) Florian Grebien et al. Nature Chemical Biology
- Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
- (2014) B. Xu et al. BLOOD
- Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
- (2014) Fang Cao et al. MOLECULAR CELL
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation
- (2013) Wenbo Li et al. NATURE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction
- (2013) Yuri Bolshan et al. ACS Medicinal Chemistry Letters
- Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
- (2012) Guillermo Senisterra et al. BIOCHEMICAL JOURNAL
- Structural Basis for WDR5 Interaction (Win) Motif Recognition in Human SET1 Family Histone Methyltransferases
- (2012) Venkatasubramanian Dharmarajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction
- (2012) Hacer Karatas et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Characterization of a Novel WDR5-binding Site That Recruits RbBP5 through a Conserved Motif to Enhance Methylation of Histone H3 Lysine 4 by Mixed Lineage Leukemia Protein-1
- (2010) Zain Odho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Non-SET Domain Multi-subunit Methyltransferase Required for Sequential Nucleosomal Histone H3 Methylation by the Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex
- (2010) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- WDR5, a complexed protein
- (2009) Raymond C Trievel et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide
- (2008) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex
- (2008) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started